Davenport & CO LLC Bausch & Lomb Corp Transaction History

Davenport & CO LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 23, 2024	SELL	$14.87 - $17.56 $15,464 - $18,262	-1,040 Reduced 0.76%	134,913 $2.3 Million
Q3 2023 Oct 17, 2023	SELL	$16.8 - $20.99 $40,101 - $50,103	-2,387 Reduced 1.73%	135,953 $2.3 Million
Q2 2023 Jul 20, 2023	SELL	$16.03 - $20.07 $20,181 - $25,268	-1,259 Reduced 0.9%	138,340 $2.78 Million
Q1 2023 Apr 27, 2023	BUY	$15.67 - $18.91 $791,131 - $954,709	50,487 Added 56.66%	139,599 $2.43 Million
Q4 2022 Jan 20, 2023	SELL	$13.5 - $17.14 $2,794 - $3,547	-207 Reduced 0.23%	89,112 $0
Q3 2022 Oct 11, 2022	BUY	$14.23 - $17.76 $1.27 Million - $1.59 Million	89,319 New	89,319 $1.37 Million

118

37.8M

116K

299K

Ticker BLCO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 350,000,000
Market Cap $6.3B
Description
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Davenport & CO LLC with notifications on news.